As blockbusters go off patent and generics companies scramble to compete, novel drug delivery tech could be the difference-maker in the marketplace.
Tekmira Pharmaceuticals ($TKMR) fired back at Alnylam Pharmaceuticals ($ALNY) in federal court this week, with an attempt to get rid of the Massachusetts company's patent lawsuit over siRNA and lipid nanoparticle drug delivery technology.
This is growing nastier. Alnylam Pharmaceuticals ($ALNY) has fired the latest round—this time in federal court—in an ongoing patent feud with development partner Tekmira Pharmaceuticals (...
BioDelivery Sciences International ($BDSI)'s dissolvable drug delivery film to treat chronic pain from inside the cheek is still under development and endured a recent clinical setback. But it's
It's the stuff of science fiction: Batteries running on natural energy sources in the body. Yet developers of so-called "bio fuel cells" have advanced their prototypes into small-animal testing, and
There are many reasons cancer patients can dread chemotherapy. It might kill their cancer, but those who go through it often wonder if the cure is just as bad as the disease. Among the uncomfortable
Quebec-based IntelGenx received a positive ruling Tuesday in a case involving two patents owned by Biovail Laboratories, the maker of the antidepressant Wellbutrin XL. The U.S. District Court of
Lotus Pharmaceuticals, a Chinese drug developer, announced that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the
Encap Drug Delivery, based in the UK, has been awarded European and US patents for the company's DuoCap capsule delivery system. DuoCap is just what it sounds like, a capsule-within-a-capsule, or a
Soligenix has been granted European Patent 1392321, "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The patent covers the use of